Disclosure of interest: Nothing to Disclose Scientific Communications: prognosis & outcomes 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE O - ESOC25-76 LONGITUDINAL BRAIN AGEING AFTER STROKE: A MARKER FOR SECONDARY POST-STROKE DEGENERATION AND ITS RELEVANCE FOR MOTOR OUTCOME Raphael Takyi 1 , Jeanette Plantin 2 , Sylvain Charron 1 , Marc Maier 3 , Jean-Claude Baron 4 , Guillaume Turc 5 , Rosso Charlotte 6 , Clment Debacker 1 , Pavel Lindberg 1 1 Institute of Psychiatry and Neuroscience of Paris, Paris, France, 2 Karolinska Institute, Stockholm, Sweden, 3 Universit Paris Cit, INCC UMR 8002, CNRS, Paris, France, 4 Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences - Neurology, Paris, France, 5 GHU-Paris Psychiatrie et Neuroscience - Neurology, Institute of Psychiatry and Neuroscience of Paris, Paris, France, 6 Sorbonne Universit, Inserm U 1127, APHP Urgences CrebroVasculaires, Hpital Piti- Salptrire, CNRS UMR 7225, STARE team, iCRIN, Inst
and Olivry, T
Well explore what each peptide does and who can benefit most, helping you understand how they can support your journey to optimal health
Copper Peptide Research Hub Use the research hub to understand GHK-Cu, ingredients and routine order
In previous years, the agency approved the shots for broad use
Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse
